Domov › Nemalobunkový karcinóm pľúc › Kalifornia › Santa Monica
Klinické štúdie Nemalobunkový karcinóm pľúc v meste Santa Monica, CA
45 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Santa Monica a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Prebieha náborFáza 3
- Beverly Hills Cancer Center ( Site 0116), Beverly Hills · 6 míľ odtiaľ
A Study of ZW251 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- University of California Los Angeles - Cancer Care - Santa Monica (UCLA), Santa Monica
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Prebieha náborFáza 3
- Tower Cancer Research Foundation, Beverly Hills · 6 míľ odtiaľ
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 míľ odtiaľ
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Prebieha náborFáza 1/2
- UCLA - Santa Monica /ID# 271690, Santa Monica
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 míľ odtiaľ
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Prebieha náborFáza 3
- Clinical Research Advisors, LLC, Beverly Hills · 6 míľ odtiaľ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Prebieha náborFáza 3
- Tower Cancer Research Foundation, Beverly Hills · 6 míľ odtiaľ
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Prebieha náborFáza 1
- Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Prebieha náborFáza 3
- Beverly Hills Cancer Center, Beverly Hills · 6 míľ odtiaľ
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Prebieha náborFáza 1
- ALX Center 11, Santa Monica
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Prebieha náborFáza 1
- Research Site, Santa Monica
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Prebieha náborFáza 3
- Beverly Hills Cancer Center ( Site 0070), Beverly Hills · 6 míľ odtiaľ
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Prebieha náborObservačná štúdia
- UCLA Medical Center, Santa Monica
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Prebieha náborFáza 1/2
- Precision NextGen Oncology, Beverly Hills · 6 míľ odtiaľ
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- Kivu Trial Site, Santa Monica
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Prebieha náborFáza 3
- Research Site, Beverly Hills · 6 míľ odtiaľ
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Prebieha náborFáza 3
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6 míľ odtiaľ
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 3
- Research Site, Beverly Hills · 6 míľ odtiaľ
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Prebieha náborFáza 3
- Clinical Study Site, Beverly Hills · 6 míľ odtiaľ
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Prebieha náborFáza 3
- Sarcoma Oncology Center, Santa Monica
- University of California Los Angeles, Santa Monica
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- UCLA, Santa Monica
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Prebieha náborFáza 1
- UCLA Health - Santa Monica Cancer Care, Santa Monica
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Research Site, Santa Monica
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Prebieha náborFáza 1/2
- UCLA - David Geffen School of Medicine, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · 6 míľ odtiaľ
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- University of California, Los Angeles (UCLA), Santa Monica
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- Cedars-Sinai Cancer at Beverly Hills (THO), Beverly Hills · 6 míľ odtiaľ
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Prebieha náborFáza 1
- UCLA Healthcare Hematology-Oncology, Santa Monica
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Prebieha náborFáza 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6 míľ odtiaľ
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Prebieha náborFáza 1
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- Research Site, Santa Monica
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Prebieha náborFáza 1
- Sarcoma Oncology Center, Santa Monica
- Precision NextGen Oncology and Research Center, Beverly Hills · 6 míľ odtiaľ
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Tower Cancer Research Foundation, Beverly Hills · 6 míľ odtiaľ
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Prebieha náborFáza 1
- UCLA Santa Monica Hematology Oncology, Santa Monica
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- UCLA, Santa Monica
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Tower Cancer Research Foundation, Beverly Hills · 6 míľ odtiaľ
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 míľ odtiaľ
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 míľ odtiaľ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Tower Cancer Research Foundation, Beverly Hills · 6 míľ odtiaľ
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 míľ odtiaľ
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Prebieha náborFáza 2
- Precision NextGen Oncology and Research Center, Beverly Hills · 6 míľ odtiaľ
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Prebieha nábor
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 míľ odtiaľ
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Research Site 128, Santa Monica
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Prebieha náborFáza 1/2
- Precision NextGen Oncology, Beverly Hills · 6 míľ odtiaľ
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
Prebieha náborFáza 1
- Beverly Hills Cancer Center, Beverly Hills · 6 míľ odtiaľ
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- Precision NextGen Oncology, Beverly Hills · 6 míľ odtiaľ
Štúdie Nemalobunkový karcinóm pľúc v iných mestách
- Houston, TX145 štúdií
- New York City, NY121 štúdií
- Arlington, VA104 štúdií
- Nashville, TN97 štúdií
- Boston, MA90 štúdií
- Los Angeles, CA87 štúdií
- St. Louis, MO73 štúdií
- Chicago, IL61 štúdií
- Baltimore, MD60 štúdií
- San Antonio, TX59 štúdií
- Columbus, OH57 štúdií
- Washington, DC55 štúdií
Iné štúdie v Santa Monica
- Rakovina prsníka28 štúdií
- Kolorektálny karcinóm23 štúdií
- Rakovina (všetky typy)22 štúdií
- Metastatická rakovina19 štúdií
- Rakovina pľúc15 štúdií
- Rakovina vaječníkov15 štúdií
- Rakovina prostaty15 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku13 štúdií
- Srdcové zlyhanie11 štúdií
- Rakovina endometria10 štúdií
- Rakovina žalúdka9 štúdií
- Rakovina pankreasu9 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.